Market Overview:
The global sterile hemostatic sponge market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of trauma and accidents, rising demand for minimally invasive surgeries, and technological advancements in hemostatic products. Based on type, the global sterile hemostatic sponge market is segmented into gelatin, chitosan, collagen, and other types. Gelatin-based sponges are expected to dominate the market during the forecast period owing to their high absorbency capacity and biocompatibility. Chitosan-based sponges are also anticipated to witness significant growth due its antimicrobial properties that help reduce infection risk. Based on application, surgical wound care dominates the global sterile hemostatic sponge market followed by general wound care applications.
Product Definition:
A sterile hemostatic sponge is a medical device that is used to control bleeding. It is a small, compressible sponge that can be packed into a wound to absorb blood and help to form a clot.
Gelatin:
Gelatin is a protein derived from collagen. It has the ability to absorb small quantities of water and expand greatly when it comes in contact with the air, thereby producing a gel. Gelatin is used as an adhesive for manufacturing hemostatic sponges or sponges that are used to stop bleeding by absorbing blood. The hemostatic sponge thus formed can be inserted into the wound and act as a sealant, preventing further leakage of blood.
Chitosan:
Chitosan is a natural polymer and an amino sugar derived from the shells of crab, lobster, shrimp, and crayfish. It has been used in wound healing applications due to its ability to promote angiogenesis (the growth of new blood vessels), inhibit metalloproteinase activity (a property that helps prevent tissue damage), reduce inflammation by inhibiting cytokine production & enhancing anti-inflammatory actions.
It also enhances the biological activities of platelets.
Application Insights:
The surgical wound care segment dominated the global market in 2017. The rising cases of chronic diseases, especially diabetes, and increasing number of surgeries are the major factors driving the segment growth. According to a study published by NCBI in 2018, it was estimated that around 1% to 2% of population have suffered from a surgical or traumatic injury at least once in their lifetime. In addition, as per WHO data published in 2019, around 17 million people annually suffer from injuries worldwide with about 9.3 million being treated within 72 hours by healthcare providers who do not use any form of sterile hemostatic sponge for closure of wounds.
General wound care application is anticipated to witness significant growth over the forecast period owing to rising awareness regarding preventable diseases and an increase incidences related with accidents & trauma across various regions including North America.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities and a large number of local manufacturers are among the key factors contributing to its largest share. In addition, increasing R&D activities for new product development is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness significant growth over the coming years owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China, India, Thailand, Malaysia and Indonesia. Growing medical tourism industry due to low cost of treatment is also expected boost demand for sterility products over the forecast period.
Growth Factors:
- Increasing incidence of traumatic injuries: The increasing incidence of traumatic injuries is one of the key growth drivers for the global sterile hemostatic sponge market. Traumatic injuries are caused by external forces that lead to tissue damage, and they are a major cause of death worldwide. According to the World Health Organization (WHO), road traffic accidents are the leading cause of death among people aged 15-29 years. In addition, wars and natural disasters also contribute to a high number of traumatic injuries every year. This is expected to drive demand for sterile hemostatic sponges in the coming years.
- Rising awareness about hemostasis: Hemostasis is a medical term used to describe the process of stopping bleeding from an injured blood vessel. There has been an increase in awareness about hemostasis in recent years, owing to rising incidences of trauma cases around the world. This has led to an increase in demand for sterile hemostatic sponges as they help control bleeding quickly and effectively.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sterile Hemostatic Sponge Market Research Report
By Type
Gelatin, Chitosan, Collagen, Other
By Application
Surgical Wound Care, General Wound Care
By Companies
Bard, Pfizer, Johnson & Johnson, Baxter, Ferrosan Medical Devices, B Braun, Gelita Medical, Equimedical, Biocer, Celox, Hemostasis, MBP, Medira, Hemotec Medical, Starch Medical, Success Pharmaceutical, Changsha Hairun
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Sterile Hemostatic Sponge Market Report Segments:
The global Sterile Hemostatic Sponge market is segmented on the basis of:
Types
Gelatin, Chitosan, Collagen, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical Wound Care, General Wound Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bard
- Pfizer
- Johnson & Johnson
- Baxter
- Ferrosan Medical Devices
- B Braun
- Gelita Medical
- Equimedical
- Biocer
- Celox
- Hemostasis
- MBP
- Medira
- Hemotec Medical
- Starch Medical
- Success Pharmaceutical
- Changsha Hairun
Highlights of The Sterile Hemostatic Sponge Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gelatin
- Chitosan
- Collagen
- Other
- By Application:
- Surgical Wound Care
- General Wound Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sterile Hemostatic Sponge Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A sterile hemostatic sponge is a medical device that helps to stop bleeding. It is made of absorbent material, such as gauze or cotton, and has a hole in the center. When placed over the wound, the sponge absorbs blood and pressure from the surrounding area. This reduces bleeding and helps to prevent infection.
Some of the major players in the sterile hemostatic sponge market are Bard, Pfizer, Johnson & Johnson, Baxter, Ferrosan Medical Devices, B Braun, Gelita Medical, Equimedical, Biocer, Celox, Hemostasis, MBP, Medira, Hemotec Medical, Starch Medical, Success Pharmaceutical, Changsha Hairun.
The sterile hemostatic sponge market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sterile Hemostatic Sponge Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sterile Hemostatic Sponge Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sterile Hemostatic Sponge Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sterile Hemostatic Sponge Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sterile Hemostatic Sponge Market Size & Forecast, 2020-2028
4.5.1 Sterile Hemostatic Sponge Market Size and Y-o-Y Growth
4.5.2 Sterile Hemostatic Sponge Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gelatin
5.2.2 Chitosan
5.2.3 Collagen
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgical Wound Care
6.2.2 General Wound Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sterile Hemostatic Sponge Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sterile Hemostatic Sponge Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gelatin
9.6.2 Chitosan
9.6.3 Collagen
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgical Wound Care
9.10.2 General Wound Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gelatin
10.6.2 Chitosan
10.6.3 Collagen
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgical Wound Care
10.10.2 General Wound Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gelatin
11.6.2 Chitosan
11.6.3 Collagen
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgical Wound Care
11.10.2 General Wound Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gelatin
12.6.2 Chitosan
12.6.3 Collagen
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgical Wound Care
12.10.2 General Wound Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gelatin
13.6.2 Chitosan
13.6.3 Collagen
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgical Wound Care
13.10.2 General Wound Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sterile Hemostatic Sponge Market: Competitive Dashboard
14.2 Global Sterile Hemostatic Sponge Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bard
14.3.2 Pfizer
14.3.3 Johnson & Johnson
14.3.4 Baxter
14.3.5 Ferrosan Medical Devices
14.3.6 B Braun
14.3.7 Gelita Medical
14.3.8 Equimedical
14.3.9 Biocer
14.3.10 Celox
14.3.11 Hemostasis
14.3.12 MBP
14.3.13 Medira
14.3.14 Hemotec Medical
14.3.15 Starch Medical
14.3.16 Success Pharmaceutical
14.3.17 Changsha Hairun
